June 25, 2008
DoD Awards Morphotek $1.7M for Bio-defense Therapeutics
Comments | Print | Email | Archives | Copyright Permissions |
Morphotek has received $1.7 million in funding approval from the Defense Department to further develop biologic-based monoclonal antibody (mAb) therapies targeting...
Copyright © 2008 Access Intelligence, LLC. All rights reserved. Reproduction in whole or in part in any form or medium without express written permission of Access Intelligence, LLC is prohibited.